| 000 | 01856 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514221929.0 | ||
| 264 | 0 | _c20050519 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a0167-6806 | ||
| 024 | 7 |
_a10.1007/s10549-004-2624-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCorte, M Daniela | |
| 245 | 0 | 0 |
_aTissue-type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cMar 2005 |
||
| 300 |
_a33-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aBreast Neoplasms _xmortality |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCytosol _xmetabolism |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aSpain _xepidemiology |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xmetabolism |
| 700 | 1 | _aVérez, Paula | |
| 700 | 1 | _aRodríguez, Juan Carlos | |
| 700 | 1 | _aRoibás, Antonio | |
| 700 | 1 | _aDomínguez, M Luz | |
| 700 | 1 | _aLamelas, M Luz | |
| 700 | 1 | _aVázquez, Julio | |
| 700 | 1 | _aGarcía Muñiz, José L | |
| 700 | 1 | _aAllende, M Teresa | |
| 700 | 1 | _aGonzález, Luis Ovidio | |
| 700 | 1 | _aFueyo, Antonio | |
| 700 | 1 | _aVizoso, Francisco | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 90 _gno. 1 _gp. 33-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-004-2624-x _zAvailable from publisher's website |
| 999 |
_c15442941 _d15442941 |
||